Crinetics Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Business Update
Go back to Crinetics Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Business Update| (NASDAQ: CRNX) | Delayed: 84.95 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $84.95 | 52 Week High | $ | |||
| Open | $84.95 | 52 Week Low | $ | |||
| Day High | $84.95 | P/E | N/A | |||
| Day Low | $84.95 | EPS | $ | |||
| Volume | 1,461,784 | |||||
| Vertex Pharmaceuticals Inc (NASDAQ: VRTX) | Delayed: 510.72 +2.38 (0.47%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $508.34 | 52 Week High | $134.71 | |||
| Open | $506.85 | 52 Week Low | $73.31 | |||
| Day High | $514.10 | P/E | N/A | |||
| Day Low | $501.01 | EPS | $-1.98 | |||
| Volume | 906,636 | |||||
